Therapeutic consequences of pathology and prognostic factors in aggressive NHL - Analysis of ALCL

Annals of Hematology, Supplement

Volumn 80, Issue 3, 2001, Pages B45-B48

  Gascoyne, R D ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD30 ANTIGEN; MONOCLONAL ANTIBODY; NUCLEOPHOSMIN;

ANAPLASTIC CARCINOMA; B CELL LYMPHOMA; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SKIN LYMPHOMA; T CELL LYMPHOMA;

ACTIVIN RECEPTORS, TYPE I; ACTIVIN RECEPTORS, TYPE II; ANTIGENS, CD30; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, HIGH-GRADE; LYMPHOMA, LARGE-CELL; PROGNOSIS; PROTEIN-TYROSINE KINASES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035204027     PISSN: 09458077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ALK-positive lymphoma: A single disease with a broad spectrum of morphology
2. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immuno-deficiency virus
3. Anaplastic large cell lymphoma: Redefining its morphologic spectrum and importance of recognition of the ALK-positive subset
4. Ki-1-positive large cell lymphoma. A clinico-pathologic study of 41 cases
5. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype
6. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation
7. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum
8. ALK+ lymphoma: Clinico-pathological findings and outcome
9. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma
10. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas
11. Report of the Clinical Advisory Committee meeting Airlie House, Virginia, November 1997
12. The t(2;5) in human lymphomas
13. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics
14. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma
15. Expression of the ALK tyrosine kinase gene in neuroblastoma
16. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
17. Anaplastic large cell lymphoma: A distinct molecular pathologic entity: A reappraisal with special reference to p80(NPM/ALK) expression
18. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements
19. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
20. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: A distinct clinicopathologic entity
21. Anaplastic large cell lymphoma: A clinicopathologic analysis
22. Updated Kiel classification for lymphomas
23. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
24. CD30(+) anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features
25. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
26. Primary anaplastic large-cell lymphoma in adults: Clinical presentation, immunophenotype, and outcome
27. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma
28. Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas